CAROTTI, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 2.820
AS - Asia 2.575
EU - Europa 1.088
SA - Sud America 414
AF - Africa 335
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 15
Totale 7.270
Nazione #
US - Stati Uniti d'America 2.648
SG - Singapore 760
VN - Vietnam 579
CN - Cina 459
IT - Italia 352
HK - Hong Kong 285
BR - Brasile 281
DE - Germania 99
FR - Francia 86
IN - India 68
BD - Bangladesh 65
FI - Finlandia 64
GB - Regno Unito 63
PL - Polonia 58
NL - Olanda 51
BJ - Benin 46
SE - Svezia 38
IQ - Iraq 35
AR - Argentina 34
RU - Federazione Russa 31
ZA - Sudafrica 31
TR - Turchia 30
CA - Canada 29
ID - Indonesia 29
MX - Messico 28
CI - Costa d'Avorio 27
EC - Ecuador 25
JP - Giappone 23
SA - Arabia Saudita 19
VE - Venezuela 18
PH - Filippine 17
EG - Egitto 16
UA - Ucraina 16
AT - Austria 15
MY - Malesia 15
AO - Angola 14
ES - Italia 13
MD - Moldavia 13
PK - Pakistan 13
RS - Serbia 13
UZ - Uzbekistan 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
PA - Panama 12
CO - Colombia 11
ET - Etiopia 11
GR - Grecia 11
JM - Giamaica 11
NP - Nepal 11
TH - Thailandia 11
AE - Emirati Arabi Uniti 10
DO - Repubblica Dominicana 10
IE - Irlanda 10
JO - Giordania 10
KE - Kenya 10
LB - Libano 10
LY - Libia 10
MA - Marocco 10
NE - Niger 10
RO - Romania 10
AZ - Azerbaigian 9
BY - Bielorussia 9
CL - Cile 9
DZ - Algeria 9
GE - Georgia 9
KG - Kirghizistan 9
NI - Nicaragua 9
PS - Palestinian Territory 9
XK - ???statistics.table.value.countryCode.XK??? 9
BO - Bolivia 8
BW - Botswana 8
CV - Capo Verde 8
IL - Israele 8
MK - Macedonia 8
PT - Portogallo 8
TJ - Tagikistan 8
TT - Trinidad e Tobago 8
BA - Bosnia-Erzegovina 7
BE - Belgio 7
BZ - Belize 7
HN - Honduras 7
HR - Croazia 7
HT - Haiti 7
IS - Islanda 7
KZ - Kazakistan 7
ME - Montenegro 7
NO - Norvegia 7
PE - Perù 7
PY - Paraguay 7
SK - Slovacchia (Repubblica Slovacca) 7
SO - Somalia 7
TN - Tunisia 7
TW - Taiwan 7
UY - Uruguay 7
AU - Australia 6
CW - ???statistics.table.value.countryCode.CW??? 6
DJ - Gibuti 6
EE - Estonia 6
GP - Guadalupe 6
IR - Iran 6
Totale 7.021
Città #
Singapore 451
Ashburn 447
San Jose 393
Hong Kong 254
Ho Chi Minh City 171
Fairfield 152
Hanoi 136
Chandler 135
Los Angeles 104
Beijing 103
Cambridge 82
Woodbridge 82
Ann Arbor 77
Padova 74
Santa Clara 68
New York 58
Houston 56
Seattle 52
Cotonou 46
Wilmington 45
Da Nang 44
Helsinki 42
Munich 41
Milan 38
Boardman 37
Bytom 34
São Paulo 34
Council Bluffs 33
Lauterbourg 31
Charlottesville 29
Abidjan 26
Buffalo 25
Orem 24
Medford 23
Princeton 23
Haiphong 22
San Diego 22
Warsaw 22
Noale 19
Tokyo 18
Chennai 17
London 16
Redondo Beach 16
Amsterdam 15
Atlanta 15
Des Moines 15
Montreal 15
Frankfurt am Main 14
Johannesburg 14
Turku 14
Denver 13
Padua 13
The Dalles 13
Hefei 12
Marseille 12
Stockholm 12
Tashkent 12
Baghdad 11
Hải Dương 11
Istanbul 11
Luanda 11
Addis Ababa 10
Belgrade 10
Brooklyn 10
Guayaquil 10
Nuremberg 10
Poplar 10
Rio de Janeiro 10
Amman 9
Baku 9
Bishkek 9
Dublin 9
Kingston 9
Nairobi 9
Ninh Bình 9
Phủ Lý 9
Vienna 9
Biên Hòa 8
Chisinau 8
Edmond 8
Managua 8
Mexico City 8
Nha Trang 8
Panama City 8
Praia 8
Quito 8
Rome 8
San Francisco 8
Vũng Tàu 8
Athens 7
Cairo 7
Chicago 7
Dallas 7
Dushanbe 7
Falkenstein 7
Guangzhou 7
Kuala Lumpur 7
Montevideo 7
Niamey 7
Paris 7
Totale 4.179
Nome #
Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation 315
Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells 286
Human Tyrosinase Produced in Insect Cells: A Landmark for the Screening of New Drugs Addressing its Activity 275
CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3 270
2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors 254
Emerging therapeutic strategies for sarcoglycanopathy 245
Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery 245
2-Hydroxypyridine-N-oxide-Embedded Aurones as Potent Human Tyrosinase Inhibitors 242
Repairing folding-defective α-sarcoglycan mutants by CFTR correctors, a potential therapy for Limb Girdle Muscular Dystrophy 2D 242
The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy 239
In vivo recovery of α-sarcoglycan mutants by protein folding correctors 230
Zebrafish as a model for sarcoglycanopathies: in-depth analysis of the disease phenotype 221
Brody Disease: Utilizing a Novel Zebrafish Animal Model for Exploring Potential Therapeutic Strategies for this Rare Human Condition 213
The Accordion Zebrafish tq206 Mutant in the Assessment of a Novel Pharmaceutical Approach to Brody Myopathy 212
Novel therapeutic perspectives for sarcoglycanopathy: rescue of folding-defective mutants by means of protein folding correctors 204
Sarcoglycanopathies, therapeutic approaches based on small molecules 196
CFTR correctors for the treatment of type 2D Limb Girdle Muscular Dystrophy 196
Novel animal models for sarcoglycanopathy 191
Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy—Assessment of Patient’s Primary Myotubes 187
In vivo proof of concept of the efficacy of the CFTR corrector C17 in a sarcoglycanopathy mouse model 184
C17 corrector for the treatment of sarcoglycanopathy: preliminary ADME studies 184
Ditopic Chelators of Dicopper Centers for Enhanced Tyrosinases Inhibition 179
Synthesis and Evaluation of Bithiazole Derivatives As Potential α-Sarcoglycan Correctors 175
From the molecular mechanism to novel pharmacological approaches, the story of a muscular dystrophy. 175
In vivo rescue of α-sarcoglycan mutants by CFTR correctors 175
Small molecules to rescue folding-defective sarcoglycans: in vivo assessment of novel therapeutic strategies 169
Brody Disease: A Novel Zebrafish Animal Model to Test Potential Therapeutic Approach for This Rare Human Disease 167
Rescue of folding-defective alpha-sarcoglycan mutants by means of protein folding correctors 162
Novel zebrafish models for sarcoglycanopathy 159
Differential Analysis of Gly211Val and Gly286Val Mutations Affecting Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA1) in Congenital Pseudomyotonia Romagnola Cattle 157
Modeling Sarcoglycanopathy in Danio rerio 156
Exploiting HOPNO-dicopper center interaction to development of inhibitors for human tyrosinase 155
Small molecules to rescue folding-defective sarcoglycans: in vivo assessment of novel therapeutic strategies 155
In vivo recovery of α-sarcoglycan mutants by protein folding correctors 152
Novel therapeutic perspectives for sarcoglycanopathy by assisting protein folding 143
Nanohybridization as a Route to a Water-Friendly Therapeutic Tool for Rescuing Misfolded Proteins 107
CFTR corrector C17 rescues defective SERCA1 in bovine pseudomyotonia: a potential therapy for Brody myopathy 70
Sonda raziometrica per la misurazione dell'ATP extracellulare 41
null 17
A bioluminescent ratiometric sensor for the measurement of extracellular ATP concentration in inflammation and cancer 11
Totale 7.356
Categoria #
all - tutte 18.931
article - articoli 11.874
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 79
selected - selezionate 0
volume - volumi 0
Totale 30.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022313 3 29 30 39 15 23 8 47 35 6 9 69
2022/2023292 36 27 9 21 45 41 2 26 44 5 31 5
2023/2024288 20 42 35 28 34 32 20 4 13 13 25 22
2024/20251.123 4 79 27 52 99 20 64 163 113 46 181 275
2025/20264.780 301 318 445 637 476 201 989 354 521 280 251 7
Totale 7.356